Thursday, May 16, 2013

How Drug Companies Keep Medicine Out of Reach - The Atlantic


The promise of delinking research and development from the actual manufacture of drugs, and why the pharmaceutical industry rejects an idea that could turn neglected diseases into profit.

No comments:

Post a Comment